Showing results (61-70 of 228) with videos related to
Sort By:
Pageof 23
Alimentary Pharmacology & Therapeutics|July 15, 1998
Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazoleJ G Hatlebakk, A BerstadScandinavian Journal of Gastroenterology|July 1, 1992
Experimental colitis in animal modelsH S Kim, A BerstadAlimentary Pharmacology & Therapeutics|April 1, 1997
Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitisJ G Hatlebakk, A BerstadScandinavian Journal of Gastroenterology|June 1, 1985
Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changesA A Nesland, A BerstadScandinavian Journal of Gastroenterology|August 1, 1997
Endoscopic grading of reflux oesophagitis: what observations correlate with gastro-oesophageal reflux?J G Hatlebakk, A BerstadScandinavian Journal of Gastroenterology|January 1, 1975
A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patientsM Roland, A Berstad, LiavågScandinavian Journal of Gastroenterology. Supplement|January 1, 1995
The predictive value of symptoms in gastro-oesophageal reflux diseaseA Berstad, J G HatlebakkScandinavian Journal of Immunology|December 7, 2010
Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative reviewG A Lied, A BerstadAlimentary Pharmacology & Therapeutics|January 1, 1993
Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studiesA Berstad, J G HatlebakkClinical Pharmacokinetics|November 1, 1996
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux diseaseJ G Hatlebakk, A BerstadPageof 23